Patients in line for ‘game-changing’ cancer drug

Two cancer patients in their 30s will become the first beneficiaries of a new liver cancer treatment which has been developed on their doorstep.

Pharma company Delcath Systems, which yesterday opened its European headquarters in Galway, has developed the drug, which is set to benefit more than 50,000 people each year.

Delcath Systems developed the Chemosat drug delivery system, which enables the delivery of a concentrated dose of chemotherapy to the liver.